Expression of Extracellular Superoxide Dismutase Protein in Diabetes

  • Kim, Chul Han (Department of Plastic and Reconstructive Surgery, Soonchunhyang University College of Medicine)
  • Received : 2013.02.15
  • Accepted : 2013.07.04
  • Published : 2013.09.15


Background Diabetes is characterized by chronic hyperglycemia, which can increase reactive oxygen species (ROS) production by the mitochondrial electron transport chain. The formation of ROS induces oxidative stress and activates oxidative damage-inducing genes in cells. No research has been published on oxidative damage-related extracellular superoxide dismutase (EC-SOD) protein levels in human diabetic skin. We investigated the expression of EC-SOD in diabetic skin compared with normal skin tissue in vivo. Methods The expression of EC-SOD protein was evaluated by western blotting in 6 diabetic skin tissue samples and 6 normal skin samples. Immunohistochemical staining was also carried out to confirm the EC-SOD expression level in the 6 diabetic skin tissue samples. Results The western blotting showed significantly lower EC-SOD protein expression in the diabetic skin tissue than in the normal tissue. Immunohistochemical examination of EC-SOD protein expression supported the western blotting analysis. Conclusions Diabetic skin tissues express a relatively small amount of EC-SOD protein and may not be protected against oxidative stress. We believe that EC-SOD is related to the altered metabolic state in diabetic skin, which elevates ROS production.


Supported by : Soonchunhyang University


  1. Zelko IN, Mariani TJ, Folz RJ. Superoxide dismutase multigene family: a comparison of the CuZn-SOD (SOD1), Mn- SOD (SOD2), and EC-SOD (SOD3) gene structures, evolution, and expression. Free Radic Biol Med 2002;33:337-49.
  2. Bonnefont-Rousselot D, Bastard JP, Jaudon MC, et al. Consequences of the diabetic status on the oxidant/antioxidant balance. Diabetes Metab 2000;26:163-76.
  3. West IC. Radicals and oxidative stress in diabetes. Diabet Med 2000;17:171-80.
  4. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001;414:813-20.
  5. Chance B, Sies H, Boveris A. Hydroperoxide metabolism in mammalian organs. Physiol Rev 1979;59:527-605.
  6. Fukai T, Folz RJ, Landmesser U, et al. Extracellular superoxide dismutase and cardiovascular disease. Cardiovasc Res 2002;55:239-49.
  7. Stralin P, Karlsson K, Johansson BO, et al. The interstitium of the human arterial wall contains very large amounts of extracellular superoxide dismutase. Arterioscler Thromb Vasc Biol 1995;15:2032-6.
  8. Kimura F, Hasegawa G, Obayashi H, et al. Serum extracellular superoxide dismutase in patients with type 2 diabetes: relationship to the development of micro- and macrovascular complications. Diabetes Care 2003;26:1246-50.
  9. McCord JM, Fridovich I. Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). J Biol Chem 1969;244:6049-55.
  10. Fridovich I. Superoxide radical and superoxide dismutases. Annu Rev Biochem 1995;64:97-112.
  11. Oury TD, Day BJ, Crapo JD. Extracellular superoxide dismutase: a regulator of nitric oxide bioavailability. Lab Invest 1996;75:617-36.
  12. St Clair DK, Oberley TD, Muse KE, et al. Expression of manganese superoxide dismutase promotes cellular differentiation. Free Radic Biol Med 1994;16:275-82.
  13. Hendrickson DJ, Fisher JH, Jones C, et al. Regional localization of human extracellular superoxide dismutase gene to 4pter-q21. Genomics 1990;8:736-8.
  14. Marklund SL. Human copper-containing superoxide dismutase of high molecular weight. Proc Natl Acad Sci U S A 1982;79:7634-8.
  15. Adachi T, Inoue M, Hara H, et al. Relationship of plasma extracellular-superoxide dismutase level with insulin resistance in type 2 diabetic patients. J Endocrinol 2004;181:413-7.
  16. Adachi T, Nakamura M, Yamada H, et al. Quantitative and qualitative changes of extracellular-superoxide dismutase in patients with various diseases. Clin Chim Acta 1994;229:123-31.
  17. Sentman ML, Jonsson LM, Marklund SL. Enhanced alloxan- induced beta-cell damage and delayed recovery from hyperglycemia in mice lacking extracellular-superoxide dismutase. Free Radic Biol Med 1999;27:790-6.
  18. Yamada H, Yamada Y, Adachi T, et al. Protective role of extracellular superoxide dismutase in hemodialysis patients. Nephron 2000;84:218-23.